These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 22120718)

  • 21. Practice-Changing Abstracts From the 2016 Society for Neuro-Oncology Annual Scientific Meeting.
    Penas-Prado M
    Am Soc Clin Oncol Educ Book; 2017; 37():187-191. PubMed ID: 28561706
    [TBL] [Abstract][Full Text] [Related]  

  • 22. MR Imaging-derived Oxygen Metabolism and Neovascularization Characterization for Grading and IDH Gene Mutation Detection of Gliomas.
    Stadlbauer A; Zimmermann M; Kitzwögerer M; Oberndorfer S; Rössler K; Dörfler A; Buchfelder M; Heinz G
    Radiology; 2017 Jun; 283(3):799-809. PubMed ID: 27982759
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Impending Impact of Molecular Pathology on Classifying Adult Diffuse Gliomas.
    Macaulay RJ
    Cancer Control; 2015 Apr; 22(2):200-5. PubMed ID: 26068765
    [TBL] [Abstract][Full Text] [Related]  

  • 24. IDH-mutant glioma specific association of rs55705857 located at 8q24.21 involves MYC deregulation.
    Oktay Y; Ülgen E; Can Ö; Akyerli CB; Yüksel Ş; Erdemgil Y; Durası IM; Henegariu OI; Nanni EP; Selevsek N; Grossmann J; Erson-Omay EZ; Bai H; Gupta M; Lee W; Turcan Ş; Özpınar A; Huse JT; Sav MA; Flanagan A; Günel M; Sezerman OU; Yakıcıer MC; Pamir MN; Özduman K
    Sci Rep; 2016 Jun; 6():27569. PubMed ID: 27282637
    [TBL] [Abstract][Full Text] [Related]  

  • 25. High frequency of IDH-1 mutation links glioneuronal tumors with neuropil-like islands to diffuse astrocytomas.
    Huse JT; Nafa K; Shukla N; Kastenhuber ER; Lavi E; Hedvat CV; Ladanyi M; Rosenblum MK
    Acta Neuropathol; 2011 Sep; 122(3):367-9. PubMed ID: 21755347
    [No Abstract]   [Full Text] [Related]  

  • 26. From GWAS risk foci to glioma molecular subclass.
    Yung WK
    Neuro Oncol; 2013 May; 15(5):513-4. PubMed ID: 23620433
    [No Abstract]   [Full Text] [Related]  

  • 27. IDH mutation, 1p19q codeletion and ATRX loss in WHO grade II gliomas.
    Leeper HE; Caron AA; Decker PA; Jenkins RB; Lachance DH; Giannini C
    Oncotarget; 2015 Oct; 6(30):30295-305. PubMed ID: 26210286
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Impact of gross total resection in patients with WHO grade III glioma harboring the IDH 1/2 mutation without the 1p/19q co-deletion.
    Kawaguchi T; Sonoda Y; Shibahara I; Saito R; Kanamori M; Kumabe T; Tominaga T
    J Neurooncol; 2016 Sep; 129(3):505-514. PubMed ID: 27401154
    [TBL] [Abstract][Full Text] [Related]  

  • 29. IDH Mutation, Competitive Inhibition of FTO, and RNA Methylation.
    Elkashef SM; Lin AP; Myers J; Sill H; Jiang D; Dahia PLM; Aguiar RCT
    Cancer Cell; 2017 May; 31(5):619-620. PubMed ID: 28486104
    [No Abstract]   [Full Text] [Related]  

  • 30. IDH1 mutations in gliomas: when an enzyme loses its grip.
    Frezza C; Tennant DA; Gottlieb E
    Cancer Cell; 2010 Jan; 17(1):7-9. PubMed ID: 20129244
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Management of diffusely infiltrating glioma in the elderly.
    Wirsching HG; Happold C; Roth P; Weller M
    Curr Opin Oncol; 2015 Nov; 27(6):502-9. PubMed ID: 26397765
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Increased plasma d-2-hydroxyglutarate in isocitrate dehydrogenase 2-mutated blastic plasmacytoid dendritic cell neoplasm.
    Rakheja D; Fuda F; Vandergriff T; Boriack R; Medeiros BC; Frankel AE; Chen W
    Hum Pathol; 2015 Feb; 46(2):322-6. PubMed ID: 25481493
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Updates in Molecular Pathology of Central Nervous System Gliomas in Adults.
    Punsoni M; Donahue JE; Elinzano HD; Kinsella T
    R I Med J (2013); 2015 Nov; 98(11):17-9. PubMed ID: 26517249
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Diffuse glioma - Rare homozygous IDH point mutation, is it an oncogenetic mechanism?
    Singh A; Gurav M; Dhanavade S; Shetty O; Epari S
    Neuropathology; 2017 Dec; 37(6):582-585. PubMed ID: 28782849
    [TBL] [Abstract][Full Text] [Related]  

  • 35. IDH mutations in glioma and acute myeloid leukemia.
    Dang L; Jin S; Su SM
    Trends Mol Med; 2010 Sep; 16(9):387-97. PubMed ID: 20692206
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Selective Detection of the D-enantiomer of 2-Hydroxyglutarate in the CSF of Glioma Patients with Mutated Isocitrate Dehydrogenase.
    Kalinina J; Ahn J; Devi NS; Wang L; Li Y; Olson JJ; Glantz M; Smith T; Kim EL; Giese A; Jensen RL; Chen CC; Carter BS; Mao H; He M; Van Meir EG
    Clin Cancer Res; 2016 Dec; 22(24):6256-6265. PubMed ID: 27340277
    [TBL] [Abstract][Full Text] [Related]  

  • 37. TERT promoter mutated WHO grades II and III gliomas are located preferentially in the frontal lobe and avoid the midline.
    Sun ZL; Chan AK; Chen LC; Tang C; Zhang ZY; Ding XJ; Wang Y; Sun CR; Ng HK; Yao Y; Zhou LF
    Int J Clin Exp Pathol; 2015; 8(9):11485-94. PubMed ID: 26617880
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Insulator dysfunction and oncogene activation in IDH mutant gliomas.
    Flavahan WA; Drier Y; Liau BB; Gillespie SM; Venteicher AS; Stemmer-Rachamimov AO; Suvà ML; Bernstein BE
    Nature; 2016 Jan; 529(7584):110-4. PubMed ID: 26700815
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Cancer: Oncogene brought into the loop.
    Grimmer MR; Costello JF
    Nature; 2016 Jan; 529(7584):34-5. PubMed ID: 26700812
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Advances in the molecular genetics of gliomas.
    Nagane M; Huang HJ; Cavenee WK
    Curr Opin Oncol; 1997 May; 9(3):215-22. PubMed ID: 9229142
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.